← FDA DRUG APPROVALS

FDA ANDA · ANDA073117

METOCLOPRAMIDE HYDROCHLORIDE

Sponsor: HOSPIRA

APPLICATION
ANDA073117
TYPE
ANDA
ORIGINAL APPROVAL
1991-01-17
LATEST ACTION
2002-12-09
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

METOCLOPRAMIDE HYDROCHLORIDEDiscontinued
METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/ML · INJECTABLE · INJECTION

Approval history

2002-12-09Labeling · Supplement 9AP
2002-02-01Labeling · Supplement 8AP
1999-09-13Labeling · Supplement 7AP
1997-11-25Labeling · Supplement 6AP
1996-10-03Manufacturing (CMC) · Supplement 4AP
1996-07-02Manufacturing (CMC) · Supplement 1AP
1995-11-30Labeling · Supplement 2AP
1991-01-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →